Negotiable
The date of payment from buyers deliver within days
Beijing
Long-term effective
2020-08-06 15:27
93
Company Profile
Xi'an Yutbon Pharmaceutical Technology Co., LtdBy certification [File Integrity]
Contact:yutebang(Mr.)
Email:
Telephone:
Phone:
Area:Beijing
Address:Beijing
Website:http://www.yutbonpharma.com/ http://yutebang.sztolips.com/
Baloxavir powder CAS 1985605-59-1, a third-generation antiviral chemical, is the first novel anti-influenza drug approved by THE US FDA in the past 20 years.
Product Name: CAS 1985605-59-1 Baloxavir powder
Synonyms: Baloxavir;CPD2051;Baloxavir Impurity 10;S-033447
CAS: 1985605-59-1
Assay: 99%
MF: C24-H19-F2-N3-O4-S
MW: 483.4931
Standard: Pharmacopoeia
Appearance: White or off-white crystalline powder
Package: In aluminium foil bag or 25kg/ drum
Product Application :
CAS 1985605-59-1 Baloxavir powder has a novel anti-influenza mechanism aimed at combating both influenza A and Influenza B viruses, including tamiflu (Oseltamivir) resistant strains and avian influenza strains (H7N9, H5N1).
Contact information:
http://www.yutbonpharma.com/